Molina Healthcare, Inc $MOH Stake Decreased by Amitell Capital Pte Ltd

Amitell Capital Pte Ltd decreased its position in shares of Molina Healthcare, Inc (NYSE:MOH) by 45.3% during the fourth quarter, according to its most recent filing with the SEC. The firm owned 20,829 shares of the company’s stock after selling 17,269 shares during the period. Molina Healthcare comprises about 4.0% of Amitell Capital Pte Ltd’s holdings, making the stock its 10th largest holding. Amitell Capital Pte Ltd’s holdings in Molina Healthcare were worth $3,615,000 at the end of the most recent reporting period.

A number of other hedge funds and other institutional investors have also recently made changes to their positions in the company. AQR Capital Management LLC grew its holdings in shares of Molina Healthcare by 217.0% during the 3rd quarter. AQR Capital Management LLC now owns 2,934,130 shares of the company’s stock worth $561,475,000 after acquiring an additional 2,008,458 shares during the period. Victory Capital Management Inc. grew its holdings in shares of Molina Healthcare by 344.3% during the 3rd quarter. Victory Capital Management Inc. now owns 963,526 shares of the company’s stock worth $184,380,000 after acquiring an additional 746,639 shares during the period. Dimensional Fund Advisors LP grew its holdings in shares of Molina Healthcare by 31.0% during the 3rd quarter. Dimensional Fund Advisors LP now owns 938,677 shares of the company’s stock worth $179,632,000 after acquiring an additional 222,346 shares during the period. Capital Research Global Investors grew its stake in shares of Molina Healthcare by 0.4% in the 4th quarter. Capital Research Global Investors now owns 795,909 shares of the company’s stock worth $138,122,000 after buying an additional 3,123 shares during the last quarter. Finally, Norges Bank purchased a new stake in shares of Molina Healthcare in the 4th quarter worth approximately $109,766,000. Hedge funds and other institutional investors own 98.50% of the company’s stock.

Wall Street Analyst Weigh In

Several analysts recently weighed in on MOH shares. Mizuho set a $215.00 price target on Molina Healthcare in a research note on Monday. Bank of America upgraded Molina Healthcare from an “underperform” rating to a “buy” rating and set a $250.00 price objective for the company in a research report on Wednesday, April 29th. UBS Group raised their target price on Molina Healthcare from $180.00 to $202.00 and gave the stock a “neutral” rating in a report on Friday, May 22nd. Deutsche Bank Aktiengesellschaft reaffirmed a “hold” rating and issued a $129.00 target price on shares of Molina Healthcare in a report on Friday, April 24th. Finally, Cantor Fitzgerald raised their price target on Molina Healthcare from $144.00 to $209.00 and gave the company a “neutral” rating in a report on Monday, May 11th. Three equities research analysts have rated the stock with a Buy rating, eleven have issued a Hold rating and two have given a Sell rating to the stock. Based on data from MarketBeat.com, the company currently has a consensus rating of “Hold” and a consensus target price of $182.73.

Molina Healthcare Price Performance

NYSE:MOH opened at $192.88 on Friday. The company has a quick ratio of 1.63, a current ratio of 1.63 and a debt-to-equity ratio of 0.97. The business’s 50-day simple moving average is $173.49 and its two-hundred day simple moving average is $164.24. The stock has a market cap of $10.05 billion, a PE ratio of 57.07 and a beta of 0.80. Molina Healthcare, Inc has a 52 week low of $121.06 and a 52 week high of $311.52.

Molina Healthcare (NYSE:MOH) last posted its quarterly earnings results on Wednesday, April 22nd. The company reported $2.35 EPS for the quarter, beating analysts’ consensus estimates of $1.57 by $0.78. The business had revenue of $10.80 billion for the quarter, compared to analysts’ expectations of $10.91 billion. Molina Healthcare had a return on equity of 8.76% and a net margin of 0.42%.The business’s quarterly revenue was down 3.1% on a year-over-year basis. During the same period last year, the firm earned $6.08 earnings per share. Molina Healthcare has set its FY 2026 guidance at 5.000- EPS. As a group, analysts forecast that Molina Healthcare, Inc will post 5.23 EPS for the current fiscal year.

Insider Transactions at Molina Healthcare

In other news, CAO Maurice Hebert sold 600 shares of the firm’s stock in a transaction dated Thursday, May 14th. The stock was sold at an average price of $191.55, for a total transaction of $114,930.00. Following the completion of the transaction, the chief accounting officer owned 12,815 shares in the company, valued at $2,454,713.25. This trade represents a 4.47% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available at the SEC website. Also, insider Jeff D. Barlow sold 17,811 shares of the firm’s stock in a transaction dated Monday, May 11th. The shares were sold at an average price of $186.12, for a total value of $3,314,983.32. Following the transaction, the insider owned 67,175 shares of the company’s stock, valued at approximately $12,502,611. The trade was a 20.96% decrease in their position. The disclosure for this sale is available in the SEC filing. Company insiders own 1.44% of the company’s stock.

Molina Healthcare Profile

Molina Healthcare, Inc is a managed care company specializing in government-sponsored health insurance programs. The company offers Medicaid managed care plans, Medicare Advantage and prescription drug plans, and individual Marketplace plans under the Affordable Care Act. Through an integrated care model, Molina emphasizes preventive and primary care services, care coordination, and disease management to improve health outcomes for its members.

The company traces its roots to the early 1980s, when Dr.